Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markolf Hanefeld

Showing results (11-20 of 121) with videos related to

Pageof 13
Sort By:
Zeitschrift Fur Arztliche Fortbildung Und Qualitatssicherung|May 23, 2002
[The metabolic syndrome and its epidemiologic dimensions in historical perspective]Markolf Hanefeld, Carsta Köhler
Pharmaceuticals (Basel, Switzerland)|February 10, 2021
The Current and Potential Therapeutic Use of Metformin-The Good Old DrugJózef Drzewoski, Markolf Hanefeld
Clinical Research in Cardiology Supplements|April 25, 2012
[Multimodal therapy of dyslipidemia]Annett Stahn, Markolf Hanefeld
Current Diabetes Reports|October 16, 2015
Hypoglycemia and Cardiovascular Disease: Lessons from Outcome StudiesFrank Pistrosch, Markolf Hanefeld
Pediatric Endocrinology, Diabetes, and Metabolism|January 24, 2015
The metabolic syndrome and cardiovascular disease - an ongoing tsunamiMarkolf Hanefeld, Frank Pistrosch
Current Diabetes Reports|February 12, 2013
Insulin use early in the course of type 2 diabetes mellitus: the ORIGIN trialMarkolf Hanefeld, Peter Bramlage
Lancet (London, England)|July 9, 2010
Dapagliflozin, an SGLT2 inhibitor, for diabetesMarkolf Hanefeld, Thomas Forst
Visceral Medicine|December 7, 2016
Metabolic Vascular Syndrome: New Insights into a Multidimensional Network of Risk Factors and DiseasesGerhard H Scholz, Markolf Hanefeld
Journal of Diabetes Science and Technology|May 31, 2014
Self-monitoring of blood glucose: a prerequisite for diabetes management in outcome trialsOliver Schnell, Markolf Hanefeld, Louis Monnier
Diabetes Care|April 29, 2011
Is hyperglycemia a cardiovascular risk factor?Frank Pistrosch, Andrea Natali, Markolf Hanefeld
Pageof 13

Showing results (11-20 of 121) with videos related to

Sort By:
Pageof 13
Zeitschrift Fur Arztliche Fortbildung Und Qualitatssicherung|May 23, 2002
[The metabolic syndrome and its epidemiologic dimensions in historical perspective]Markolf Hanefeld, Carsta Köhler
Pharmaceuticals (Basel, Switzerland)|February 10, 2021
The Current and Potential Therapeutic Use of Metformin-The Good Old DrugJózef Drzewoski, Markolf Hanefeld
Clinical Research in Cardiology Supplements|April 25, 2012
[Multimodal therapy of dyslipidemia]Annett Stahn, Markolf Hanefeld
Current Diabetes Reports|October 16, 2015
Hypoglycemia and Cardiovascular Disease: Lessons from Outcome StudiesFrank Pistrosch, Markolf Hanefeld
Pediatric Endocrinology, Diabetes, and Metabolism|January 24, 2015
The metabolic syndrome and cardiovascular disease - an ongoing tsunamiMarkolf Hanefeld, Frank Pistrosch
Current Diabetes Reports|February 12, 2013
Insulin use early in the course of type 2 diabetes mellitus: the ORIGIN trialMarkolf Hanefeld, Peter Bramlage
Lancet (London, England)|July 9, 2010
Dapagliflozin, an SGLT2 inhibitor, for diabetesMarkolf Hanefeld, Thomas Forst
Visceral Medicine|December 7, 2016
Metabolic Vascular Syndrome: New Insights into a Multidimensional Network of Risk Factors and DiseasesGerhard H Scholz, Markolf Hanefeld
Journal of Diabetes Science and Technology|May 31, 2014
Self-monitoring of blood glucose: a prerequisite for diabetes management in outcome trialsOliver Schnell, Markolf Hanefeld, Louis Monnier
Diabetes Care|April 29, 2011
Is hyperglycemia a cardiovascular risk factor?Frank Pistrosch, Andrea Natali, Markolf Hanefeld
Pageof 13